Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 22, 2004

Primary Completion Date

May 22, 2008

Study Completion Date

December 6, 2017

Conditions
Puberty, Precocious
Interventions
DRUG

Bicalutamide

oral

DRUG

Anastrozole

oral

Trial Locations (15)

19134

Research Site, Philadelphia

29615

Research Site, Greenville

32207

Research Site, Jacksonville

34295

Research Site, Montpellier

35233

Research Site, Birmingham

46202

Research Site, Indianapolis

55416

Research Site, Minneapolis

74136

Research Site, Tulsa

76508

Research Site, Temple

99204

Research Site, Spokane

110029

Research Site, New Dehli

117036

Research Site, Moscow

600020

Research Site, Chennai

N6A 4G5

Research Site, London

WC1N 3JH

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY